Form 4: Herbalife Director Perkins Miller Granted 13,626 RSUs
Statement of Changes in Beneficial Ownership
Herbalife Ltd. director Perkins Miller received a grant of 13,626 restricted stock units as part of the company's 2023 Stock Incentive Plan.
Summary
- Director Perkins Miller was granted 13,626 restricted stock units (RSUs) on May 8, 2026.
- The grant was issued under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan.
- The RSUs are valued at $0.00 at the time of grant as they represent equity-based compensation.
- Following this transaction, Miller's total beneficial ownership in the company stands at 50,769 shares.
- The units are scheduled to vest in full on April 15, 2027, provided the director remains on the board.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive administrative event that confirms ongoing director commitment and alignment with shareholder interests.
Positives
- Increases director equity ownership by 13,626 units, further aligning board interests with shareholders.
- The 100% vesting requirement in April 2027 incentivizes director retention for the upcoming year.
- Total beneficial ownership for the reporting person increased by approximately 36.6%.
Negatives
- The issuance of new units represents a future dilutive event for existing shareholders, though typical for corporate governance.
Risks
- Vesting is contingent on continued service; any premature departure from the Board of Directors would result in the forfeiture of these units.
Future Outlook
The grant ensures that a key member of the board remains incentivized through at least mid-2027, maintaining stability in corporate governance.
Management Comments
- The RSUs will vest 100% on April 15, 2027, subject to continued service on the Issuer's Board of Directors through such date.
Industry Context
StockSavvy.ai notes that equity-heavy compensation for directors is a standard practice among mid-cap consumer goods companies to ensure board members are focused on long-term stock performance rather than short-term cash gains.
Comparison to Industry Standards
- The one-year cliff vesting schedule is consistent with standard director compensation packages in the S&P MidCap 400.
- The use of an Amended and Restated Stock Incentive Plan aligns with best practices for maintaining shareholder-approved equity pools.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation Grant | Issuance of 13,626 RSUs to Director Perkins Miller. | 2026-05-08 | Strengthens the financial alignment between the board of directors and the company's shareholders. |
Related Party Transactions
- The grant of RSUs to a director under an approved incentive plan is a standard related-party compensation transaction.
Stakeholder Impact
- Shareholders: Experience minor dilution but benefit from a board with direct skin in the game.
- Board of Directors: Perkins Miller increases his personal stake in the company's long-term success.
Next Steps
- Full vesting of the 13,626 RSUs on April 15, 2027.
Key Dates
| Date | Description |
|---|---|
| 2026-05-08 | Date of the restricted stock unit grant transaction. |
| 2026-05-12 | Date the Form 4 was filed with the Securities and Exchange Commission. |
| 2027-04-15 | Scheduled vesting date for the 13,626 restricted stock units. |
Recommendation
holdThis filing represents a routine administrative compensation event and does not provide new material information regarding the company's financial performance or market position that would justify a change in investment rating.
Keywords
Herbalife, HLF, Form 4, Insider Trading, Perkins Miller, Restricted Stock Units, RSU, Director Compensation, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.